Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • GV Sanjay Reddy on India’s Energy Ambitions: Where Do We Stand in 2025 Business
  • Namitesh Roy Choudhury assumes the role of Vice Chairman and Managing Director for LANXESS India region Business
  • 10 Interesting facts about Beauty Queen Ayeesha S Aiman Every Fan should know Lifestyle
  • SBI Foundation Convenes ‘CONSERW Conclave’ to Accelerate Collaborative Climate Action for India’s Urban Ecosystems Lifestyle
  • Latest-Hashtags.com – Best Hashtag Generator Tool To Boost Social Tools & Social Accounts Business
  • Own the Moment with The Wedding Shoe Collection for Men by Language Lifestyle
  • Collegiate Esports Commissioner’s Cup Goes Global, Partners with India’s Asymmetrical Learning National
  • Mastering the Art & Science of Communication for Creativity Fueled with Confidence: Meet the talented author Er. Mandeep Singh, who is a master of scientific communication Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Genomics Unveiled: India’s Path To Precision Medicine Health
  • BIBO Health Offers Hope for Millions Battling Breathing Troubles in India Health
  • STIM Probiotic Toothpaste: Revolutionizing Oral Health with Good Bacteria, Fluoride, and Xylitol Health
  • Achieve independence from obesity to embrace a healthier life with diet and detox expert Dr Sunny Gupta Health
  • Finding the right physician is the first step to cure blood diseases Health
  • International Diabetes Organisations are unanimous on Diabetes remission through diet Health

Recent Posts

  • India’s First Global Cake Awards, IICMA 2026, Returns to New Delhi, Strengthening India’s Global Presence in Cake Artistry
  • Dev IT Strengthens Business Focus and Unlock the Value Through Transfer of ByteSIGNER and Talligence
  • Rathi Steel And Power Ltd. records 63.5 percent YOY growth in Q4 FY26 revenue, Annual Revenue surpasses Rs. 715 Crores
  • The Real Story Behind Sarkar Palmistry’s Rise In Mumbai
  • KRAFTON Launches ‘Raon,’ Its First Open-Source AI Model Family

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Great Quality & Looks at Unbelievable Price, Thunderbolt EVs Offer More Than You Can Think Business
  • A Grand Celebration of Talent and Culture: 7th Edition of Mission Dreams Miss, Mr, and Mrs India 2025–26 held in Odisha Lifestyle
  • Tide committed to serving 63-million and growing Indian SME sector to unleash their true potential Press Release
  • Mukta A2 Cinemas Opens The First Of Its Kind Luxury Signature Cinema In Ahmedabad With The Launch Of Its New 6 Screens On The Auspicious Occasion Of Dussehra    Business
  • Bong Guy: Devadutta Roy’s Quest to Conquer Hearts with Action-Packed Romance Entertainment
  • Dr Niket Patel of Akanksha IVF hospital and research institution awarded best IVF hospital by former Gujarat Deputy CM Nitin Patel Business
  • Vishal Saini collaborates with 30 crypto exchange platforms Business
  • Why Women from Across India Are Choosing Vrinda’s Academy Offline Course to Build Their Dream Careers Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme